Favorite

EpiPen lesson 

Congressional Republicans and Democrats staged a rousing display of rage against the CEO whose company gouged a fortune from families whose kids and sometimes grownups need the lifesaving properties of the drug EpiPen.

The national fury over the fleecing of sick children by Mylan N.V., which bought the rights to the allergy antidote and jacked up the price of a dose from $57 to $600, followed by the Mylan executive's rough treatment in Congress, caused some wonder. Could Washington at long last be spurred to do something about the chief driver of staggering health care inflation?

Don't be silly. Congress will do nothing of the sort. It and successive presidents have squandered every golden opportunity, including passage of two sweeping health-reform laws, the Medicare Modernization Act of 2003 and the Patient Protection and Affordable Care Act of 2010, a.k.a. Obamacare. Like previous laws, they imposed cost-saving rules on providers and insurers, but to get anything enacted Congress gave the drug companies a pass.

Since 1995, premiums for health plans have risen four times faster than family earnings and five times faster than inflation, owing mostly to drug prices and especially those of lifesaving medicine where drug companies know the market will bear any price hike.

Government, in the persons of Congress, the Food and Drug Administration and the Department of Health and Human Services, actually assists the gouging by approving bigger prescriptions — a mandatory twin pack in the case of EpiPen — or, also in the case of EpiPen, requiring many schools to stock them for emergencies. EpiPens have a brief shelf life so they must constantly be replaced. Mylan got Congress to provide block grants to states to stock EpiPens in schools.

Insurance companies merely raise premiums to cover the soaring costs. When Congress passed Medicare coverage for drugs in 2004, it defeated attempts by a few Democrats, including East Arkansas's Marion Berry, to control drug prices. Congress even barred the government from negotiating discounts for mass usage or from acquiring drugs in Europe or Canada where prices are far lower.

As critical cancer drugs went on the market the past 15 years, prices soared. A new cancer drug may cost a patient or her insurer more than $100,000 a year. Employer and individual plans often don't cover them. Cancer drugs are a leading cause of bankruptcies.

You may remember the furor last year after the egomaniac Martin Shkreli's company bought rights to a drug for a parasitic infection that was deadly for babies and AIDS sufferers. Shkreli became a symbol of Big Pharma greed when he raised the price of the drug, which had been around for decades, from $13.50 to $750 for one tablet. Shkreli, CEO of Turing Pharmaceuticals, regretted not raising it even more because people had to buy it or probably die. There was some satisfaction when the U.S. attorney in Brooklyn had Shkreli arrested. But his arrest had nothing to do with exploiting sick people. He was charged with securities fraud because he used drug profits to pay off investors who had lost money with his hedge fund.

To understand why no one messes with pharmaceutical profits, except to complain occasionally, you only have to switch on any TV channel and watch commercials for an hour. You know who pays the freight for public discourse.

Congressmen scored some points against EpiPen's blithe chief saleswoman, CEO Heather Bresch, but in the end it was her day, not theirs. The super-polite Rep. Elijah Cummings, D-Md., asked Bresch if she could confirm that her base annual salary was $18.9 million and that the EpiPen alone brought profits of "hundreds and hundreds of millions of dollars a year" for her company. She replied sweetly, yes and yes.

While Mylan was jacking up EpiPen's price annually, Bresch's salary went from $2.4 million to $18.9 million. Mylan's income was spent on more than executive pay. It spent lavishly on ads to promote what it called "increased anaphylaxis awareness": persuading people they needed easy access to EpiPens to avert their allergic child's sudden death.

Maybe a new president and Congress will be different. Donald Trump sided with Democrats on letting Medicare and Medicaid negotiate with drug companies and buy drugs from countries with socialized medicine, but otherwise he says only that he'll solve the problem as soon as he repeals Obamacare and ends health insurance for 20 million people. Big Pharma flushed lots of money into presidential campaigns, Hillary Clinton's more than any other, but she has been more critical than others of the whopping prices of generic and new drugs. She laid out a long list of things she would do to control drug prices, including getting Congress to levy stiff fines on companies that raise prices unjustifiably and importing vital drugs from countries with high safety standards.

You read it here first. None of it will happen.

Favorite

From the ArkTimes store

Speaking of EpiPen

  • The lesson of EpiPen

    September 27, 2016
    Ernest Dumas this weeks writes about the high-priced  EpiPen and it's symbolism for a Congress controlled by drug makers, as well as rising health care costs /more/
  • More »

Comments

Subscribe to this thread:

Add a comment

More by Ernest Dumas

  • Trusting

    It is a Fourth of July ritual to appraise where we are in meeting the Declaration of Independence's promise to institute a government that would, unlike King George, secure human rights equally for everyone who sets foot on American soil.
    • Jul 6, 2017
  • Obamascare

    Republicans at long last may be about to see their most fervent wishes and wildest predictions materialize — millions of people losing their medical and hospital coverage, unaffordable insurance, lost jobs, a Medicare financial crisis, mushrooming federal budget deficits and fiscal crises across state governments.
    • Jun 22, 2017
  • Ethics upended

    Every week, Donald Trump finds another way to upend conventional ethics in government and politics. Here's one that has been in the making since the campaign but is reaching maturity in the Russian investigation: He is turning the heroes of government scandals into the villains.
    • Jun 15, 2017
  • More »

Readers also liked…

  • AEC dumps ALEC

    No matter which side of the battle over global warming you're on, that was blockbuster news last week. No, not the signing of the climate-change treaty that commits all of Earth's 195 nations to lowering their greenhouse-gas emissions and slowing the heating of the planet, but American Electric Power's announcement that it would no longer underwrite efforts to block renewable energy or federal smokestack controls in the United States.
    • Dec 17, 2015
  • No tax help for Trump

    The big conundrum is supposed to be why Donald Trump does so well among white working-class people, particularly men, who do not have a college education.
    • Aug 11, 2016
  • Dollars and degrees

    Governor Hutchinson says a high graduation rate (ours is about the lowest) and a larger quotient of college graduates in the population are critical to economic development. Every few months there is another, but old, key to unlocking growth.
    • Aug 25, 2016

Most Shared

  • So much for a school settlement in Pulaski County

    The Arkansas Democrat-Gazette's Cynthia Howell got the scoop on what appears to be coming upheaval in the Pulaski County School District along with the likely end of any chance of a speedy resolution of school desegregation issues in Pulaski County.
  • Riverfest calls it quits

    The board of directors of Riverfest, Arkansas's largest and longest running music festival, announced today that the festival will no longer be held. Riverfest celebrated its 40th anniversary in June. A press release blamed competition from other festivals and the rising cost of performers fees for the decision.
  • Football for UA Little Rock

    Andrew Rogerson, the new chancellor at UA Little Rock, has decided to study the cost of starting a major college football team on campus (plus a marching band). Technically, it would be a revival of football, dropped more than 60 years ago when the school was a junior college.
  • Turn to baseball

    When the world threatens to get you down, there is always baseball — an absorbing refuge, an alternate reality entirely unto itself.

Latest in Ernest Dumas

  • The ACA can be fixed

    Majority Leader Mitch McConnell threatened his 51 disciples in the Senate and his party with the gravest injury imaginable.
    • Jul 13, 2017
  • Trusting

    It is a Fourth of July ritual to appraise where we are in meeting the Declaration of Independence's promise to institute a government that would, unlike King George, secure human rights equally for everyone who sets foot on American soil.
    • Jul 6, 2017
  • Obamascare

    Republicans at long last may be about to see their most fervent wishes and wildest predictions materialize — millions of people losing their medical and hospital coverage, unaffordable insurance, lost jobs, a Medicare financial crisis, mushrooming federal budget deficits and fiscal crises across state governments.
    • Jun 22, 2017
  • More »

Event Calendar

« »

July

S M T W T F S
  1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31  

Most Viewed

  • Pay attention

    If anyone thinks that a crisis with the Power Ultra Lounge shooting, then he hasn't been paying attention to Little Rock.
  • Another Jesus

    If you follow the logic of Jason Rapert and his supporters, God is very pleased so many have donated money to rebuild a giant stone slab with some rules on it. A few minutes on Rapert's Facebook page (if he hasn't blocked you yet) also shows his supporters believe that Jesus wants us to lock up more people in prison, close our borders to those in need and let poor Americans fend for themselves for food and health care.
  • Turn to baseball

    When the world threatens to get you down, there is always baseball — an absorbing refuge, an alternate reality entirely unto itself.
  • Football for UA Little Rock

    Andrew Rogerson, the new chancellor at UA Little Rock, has decided to study the cost of starting a major college football team on campus (plus a marching band). Technically, it would be a revival of football, dropped more than 60 years ago when the school was a junior college.

Most Recent Comments

  • Re: Another Jesus

    • I'd also add, if God were real, he'd long ravaged the indoctrined cesspool who feel…

    • on July 20, 2017
  • Re: Another Jesus

    • I could've swore that Clinton's sexual escapades were consensual.

    • on July 20, 2017
  • Re: Turn to baseball

    • Vanessa said it best "Baseball at its best suspends time." A good childhood memory I…

    • on July 20, 2017
 

© 2017 Arkansas Times | 201 East Markham, Suite 200, Little Rock, AR 72201
Powered by Foundation